Jefferies analyst Glen Santangelo downgrades Collegium Pharmaceutical (NASDAQ:COLL) from Buy to Hold and raises the price target from $30 to $37.
Jefferies Downgrades Collegium Pharmaceutical to Hold, Raises Price Target to $37
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.